BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22326833)

  • 21. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell neoplasms contain shared tumor type-specific copy number variations.
    Krill-Burger JM; Lyons MA; Kelly LA; Sciulli CM; Petrosko P; Chandran UR; Kubal MD; Bastacky SI; Parwani AV; Dhir R; LaFramboise WA
    Am J Pathol; 2012 Jun; 180(6):2427-39. PubMed ID: 22483639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
    Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.
    Yasui K; Arii S; Zhao C; Imoto I; Ueda M; Nagai H; Emi M; Inazawa J
    Hepatology; 2002 Jun; 35(6):1476-84. PubMed ID: 12029633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.
    Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M
    BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization.
    Sakakura C; Hagiwara A; Taniguchi H; Yamaguchi T; Yamagishi H; Takahashi T; Koyama K; Nakamura Y; Abe T; Inazawa J
    Br J Cancer; 1999 Aug; 80(12):2034-9. PubMed ID: 10471057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative molecular analysis of metastatic hepatocellular carcinoma.
    Wang D; Zhu Y; Tang J; Lian Q; Luo G; Wen W; Zhang MQ; Wang H; Chen L; Gu J
    BMC Med Genomics; 2019 Nov; 12(1):164. PubMed ID: 31722693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.
    Kawate S; Fukusato T; Ohwada S; Watanuki A; Morishita Y
    Oncology; 1999; 57(2):157-63. PubMed ID: 10461064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
    Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
    Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas.
    Kim HE; Kim DG; Lee KJ; Son JG; Song MY; Park YM; Kim JJ; Cho SW; Chi SG; Cheong HS; Shin HD; Lee SW; Lee JK
    PLoS One; 2012; 7(8):e43223. PubMed ID: 22912832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
    Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
    Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration.
    Li T; Wan B; Huang J; Zhang X
    Mol Genet Genomics; 2010 May; 283(5):485-92. PubMed ID: 20358383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkin gene alterations in hepatocellular carcinoma.
    Wang F; Denison S; Lai JP; Philips LA; Montoya D; Kock N; Schüle B; Klein C; Shridhar V; Roberts LR; Smith DI
    Genes Chromosomes Cancer; 2004 Jun; 40(2):85-96. PubMed ID: 15101042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
    Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
    Liu M; Yan Q; Sun Y; Nam Y; Hu L; Loong JH; Ouyang Q; Zhang Y; Li HL; Kong FE; Li L; Li Y; Li MM; Cheng W; Jiang LX; Fang S; Yang XD; Mo JQ; Gong YF; Tang YQ; Li Y; Yuan YF; Ma NF; Lin G; Ma S; Wang JG; Guan XY
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6103-6113. PubMed ID: 32123069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
    Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
    Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte-specific deletion of DDB1 induces liver regeneration and tumorigenesis.
    Yamaji S; Zhang M; Zhang J; Endo Y; Bibikova E; Goff SP; Cang Y
    Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22237-42. PubMed ID: 21135245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
    Boyault S; Rickman DS; de Reyniès A; Balabaud C; Rebouissou S; Jeannot E; Hérault A; Saric J; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
    Hepatology; 2007 Jan; 45(1):42-52. PubMed ID: 17187432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.